IL6 and neoplasm: Our data showed that SUM149-derived IL-6 confers growth stimulation to SUM190 cells through a Tocilizumab-sensitive mechanism and suggests that this paracrine effect may sustain a long-term growth-promoting equilibrium between two such tumor cell clones in vivo.